<DOC>
	<DOC>NCT01412021</DOC>
	<brief_summary>This study of Humira will be conducted to clarify the following with regard to the treatment of juvenile idiopathic arthritis affecting multiple joints with this drug: - Unknown adverse drug reactions (especially important adverse drug reactions) - Incidence and conditions of occurrence of adverse reactions in the clinical setting - Factors that may affect the safety and effectiveness of Humira</brief_summary>
	<brief_title>Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Juvenile</mesh_term>
	<criteria>All patients with Juvenile idiopathic arthritis who are not responding well to conventional therapy and receive Humira will be enrolled in the survey Contraindications according to the Package Insert Patients who have serious infections Patients who have tuberculosis Patients with a history of hypersensitivity to any ingredient of Humira Patients who have demyelinating disease or with a history of demyelinating disease Patients who have congestive cardiac failure</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Arthritis, Juvenile Rheumatoid</keyword>
</DOC>